Moderna (MRNA) earnings Q4 2023


Nikos Pekiaridis | Nurphoto | Getty Images

Moderna on Thursday posted a surprise quarterly profit, boosted by deferred revenue and cost cuts, even as the company saw slumping sales from its Covid vaccine, its only marketable product.

The results cap a rocky year for the biotech company and other Covid vaccine makers, which all saw revenue plunge as the world continued to emerge from pandemic and relied less on protective shots and treatments.

Here’s what Moderna reported for the fourth quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG, formerly known as Refinitiv:

  • Earnings per share: 55 cents. That may not be comparable to a loss of 97 cents…

Source cnbc.com

0 0 votes
Article Rating

Rolls-Royce shares jump 8% after 2023 profits more than double

Previous article

Turkey ends hiking cycle after 8 months, holding key rate at 45%

Next article

You may also like

Notify of
Inline Feedbacks
View all comments

More in Earnings